Literature DB >> 24371070

Rotavirus infection increases intestinal motility but not permeability at the onset of diarrhea.

Claudia Istrate1, Marie Hagbom, Elena Vikström, Karl-Eric Magnusson, Lennart Svensson.   

Abstract

UNLABELLED: The disease mechanisms associated with onset and secondary effects of rotavirus (RV) diarrhea remain to be determined and may not be identical. In this study, we investigated whether onset of RV diarrhea is associated with increased intestinal permeability and/or motility. To study the transit time, fluorescent fluorescein isothiocyanate (FITC)-dextran was given to RV-infected adult and infant mice. Intestinal motility was also studied with an opioid receptor agonist (loperamide) and a muscarinic receptor antagonist (atropine). To investigate whether RV increases permeability at the onset of diarrhea, fluorescent 4- and 10-kDa dextran doses were given to infected and noninfected mice, and fluorescence intensity was measured subsequently in serum. RV increased transit time in infant mice. Increased motility was detected at 24 h postinfection (h p.i.) and persisted up to 72 h p.i in pups. Both loperamide and atropine decreased intestinal motility and attenuated diarrhea. Analysis of passage of fluorescent dextran from the intestine into serum indicated unaffected intestinal permeability at the onset of diarrhea (24 to 48 h p.i.). We show that RV-induced diarrhea is associated with increased intestinal motility via an activation of the myenteric nerve plexus, which in turn stimulates muscarinic receptors on intestinal smooth muscles. IMPORTANCE: We show that RV-infected mice have increased intestinal motility at the onset of diarrhea, and that this is not associated with increased intestinal permeability. These new observations will contribute to a better understanding of the mechanisms involved in RV diarrhea.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24371070      PMCID: PMC3957942          DOI: 10.1128/JVI.02927-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Pathogenesis of intestinal and systemic rotavirus infection.

Authors:  Robert F Ramig
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues.

Authors:  J M Van Nueten; P A Janssen; J Fontaine
Journal:  Arzneimittelforschung       Date:  1974-10

3.  Prostaglandin-mediated inhibition of noradrenaline release: II. Dual mechanism behind its frequency-dependence.

Authors:  A Wennmalm
Journal:  Acta Physiol Scand       Date:  1978-02

4.  Rotavirus-induced changes in the microcirculation of intestinal villi of neonatal mice in relation to the induction and persistence of diarrhea.

Authors:  M P Osborne; S J Haddon; K J Worton; A J Spencer; W G Starkey; D Thornber; J Stephen
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-01       Impact factor: 2.839

5.  Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells.

Authors:  K G Dickman; S J Hempson; J Anderson; S Lippe; L Zhao; R Burakoff; R D Shaw
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-10       Impact factor: 4.052

6.  Development of an adult mouse model for studies on protection against rotavirus.

Authors:  R L Ward; M M McNeal; J F Sheridan
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step.

Authors:  John W A Rossen; Janneke Bouma; Rolien H C Raatgeep; Hans A Büller; Alexandra W C Einerhand
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Intestinal permeability changes and excretion of micro-organisms in stools of infants with diarrhoea and vomiting.

Authors:  L T Weaver; P D Chapman; C R Madeley; M F Laker; R Nelson
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791

9.  The effect of loperamide on prostaglandin induced diarrhoea in rat and man.

Authors:  S M Karim; P G Adaikan
Journal:  Prostaglandins       Date:  1977-02

Review 10.  The anti-inflammatory effects of prostaglandins.

Authors:  Jose U Scher; Michael H Pillinger
Journal:  J Investig Med       Date:  2009-08       Impact factor: 2.895

View more
  15 in total

1.  Peripheral Neuronopathy Associated With Ebola Virus Infection in Rhesus Macaques: A Possible Cause of Neurological Signs and Symptoms in Human Ebola Patients.

Authors:  David X Liu; Donna L Perry; Timothy K Cooper; Louis M Huzella; Randy J Hart; Amanda M W Hischak; John G Bernbaum; Lisa E Hensley; Richard S Bennett
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

2.  Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis.

Authors:  Ramanpreet Kaur; Dhimant Desai; Shantu Amin; Kaisar Raza; Aman Bhalla; Pooja Yadav; Naveen Kaushal
Journal:  Mol Cell Biochem       Date:  2022-08-24       Impact factor: 3.842

Review 3.  Mechanisms of Kwashiorkor-Associated Immune Suppression: Insights From Human, Mouse, and Pig Studies.

Authors:  Husheem Michael; Joshua O Amimo; Gireesh Rajashekara; Linda J Saif; Anastasia N Vlasova
Journal:  Front Immunol       Date:  2022-05-02       Impact factor: 8.786

Review 4.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

5.  Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology.

Authors:  Kapil Saxena; Sarah E Blutt; Khalil Ettayebi; Xi-Lei Zeng; James R Broughman; Sue E Crawford; Umesh C Karandikar; Narayan P Sastri; Margaret E Conner; Antone R Opekun; David Y Graham; Waqar Qureshi; Vadim Sherman; Jennifer Foulke-Abel; Julie In; Olga Kovbasnjuk; Nicholas C Zachos; Mark Donowitz; Mary K Estes
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

6.  The 5-HT3 Receptor Affects Rotavirus-Induced Motility.

Authors:  Marie Hagbom; Arash Hellysaz; Claudia Istrate; Johan Nordgren; Sumit Sharma; Felipe Meira de-Faria; Karl-Eric Magnusson; Lennart Svensson
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

7.  The Gastric Ganglion of Octopus vulgaris: Preliminary Characterization of Gene- and Putative Neurochemical-Complexity, and the Effect of Aggregata octopiana Digestive Tract Infection on Gene Expression.

Authors:  Elena Baldascino; Giulia Di Cristina; Perla Tedesco; Carl Hobbs; Tanya J Shaw; Giovanna Ponte; Paul L R Andrews
Journal:  Front Physiol       Date:  2017-12-15       Impact factor: 4.566

8.  Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity.

Authors:  Empar Chenoll; Beatriz Casinos; Esther Bataller; Javier Buesa; Daniel Ramón; Salvador Genovés; Joan Fábrega; Montserrat Rivero Urgell; José A Moreno Muñoz
Journal:  Front Microbiol       Date:  2016-05-04       Impact factor: 5.640

9.  Rotavirus and Serotonin Cross-Talk in Diarrhoea.

Authors:  Sonja Bialowas; Marie Hagbom; Johan Nordgren; Thommie Karlsson; Sumit Sharma; Karl-Eric Magnusson; Lennart Svensson
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

10.  Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

Authors:  Marie Hagbom; Daniel Novak; Malin Ekström; Younis Khalid; Maria Andersson; Magnus Lindh; Johan Nordgren; Lennart Svensson
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.